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The structure of potassium urate, co-crystallized with uric acid K(C5H3N4O3)(C5H4N4O3),
from human kidney stones, is determined ab initio from synchrotron powder diffraction
data, space group P21/c, a ¼ 3.60504(9) Å, b ¼ 19.9293(7) Å, c ¼ 18.4841(6) Å,
b ¼ 100.503(2), Z ¼ 4. Each uric acid molecule is connected to a urate anion through three
hydrogen bonds, both molecules are related by a pseudo-inversion center and are
randomly distributed in the crystal. Two of the oxygen atoms of the uric acid molecule and
two of the urate anions are involved in the potassium coordination forming KO7 mono-
capped trigonal prisms sharing their triangular bases, building inﬁnite chains extending
along the short a axis. Such a formulation, though controversial, has been claimed to exist
since 1862 and named potassium quadriurate. The crystal structure is optimized by energy
minimization (DFT) in the solid state, using a hybrid PBE0 functional. The capacity of the
urate anion to connect by strong hydrogen bonds to a uric acid molecule has implications
concerning the uric acid transport in biological media.
© 2015 Académie des sciences. Published by Elsevier Masson SAS. This is an open access
article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction [12] and dihydrated [13] forms, as well as monosodiumUric acid and urate salts occur as deposits in urinary
calculi [1e5] as well as in gouty arthritis [6]; a detailed
knowledge of the crystal structures involved is thus of
biological importance [7e10]. Of the compounds of bio-
logical interest, only a few are characterized crystallo-
graphically: anhydrous uric acid [11], its monohydratedMichel.Daudon@tnn.
oleil.fr (E. Elkaim),
.Smrcok@savba.sk (L.
ed by Elsevier Masson SAS.urate monohydrate [14], ammonium urate from powder
diffraction data [15] and calcium urate hexahydrate
CaUr2$6H2O [16]. Concerning the potassium derivatives it is
difﬁcult to know exactly what is behind the name “(mono)
potassium urate” abbreviated sometimes as MPU or KU,
said to be hydrated or not, and mentioned in numerous
papers including a recent report Ref. [17], since no crystal
structure is yet available. Potassium urate, KC5H3N4O3, is
number 728 in the famous Index of Powder Diffraction Data
for 1000 Chemical Substances [18], which was a seminal
work at the origin of the Powder Diffraction File (PDF)
database. This compound is still the only potassium urate in
the PDF-4 Organics database [19] with the entry numberThis is an open access article under the CC BY-NC-ND license (http://
D. Bazin et al. / C. R. Chimie 19 (2016) 1535e1541153600-001-0302. Finally, a potassium urate was claimed to be
identiﬁed in urinary tract calculi [20].
Chemically, the title compound corresponds exactly
to the “Quadrurate of potassa” KH(C5H2N4O3),
H2(C5H2N4O3) as named by Bence Jones [21], believed to
be amorphous, discussed later by Roberts [22,23] who
renamed it potassium quadriurate [23]. In this nomen-
clature, KH(C5H2N4O3) is a biurate, nowadays called
(mono)potassium urate, but this old name is still used as
a synonym by some chemical suppliers. According to Sir
William Roberts [22], the quadriurates (of K, Na, NH4)
“exist in nature in the form of the amorphous urate sedi-
ment of human urine, and as the essential constituent of
the urinary excretion of birds and serpents.” Moreover “the
quadr(i)urate is the form, and the only form, in which uric
acid exists in normal urine” and “when uric acid makes its
appearance therein, such an event is due to secondary
changes in the quadr(i)urate.” That theory of a double
salt, made up of a molecule of uric acid combined with a
molecule of an acid urate, was further examined by
Kohler [24] who declared that there was no such body as
quadriurate. We present here the ﬁrst recognized
crystalline occurrence of a potassium quadriurate as
revealed by Structure Determination by Powder
Diffractometry (SDPD) methodologies [25]. Being
microcrystalline, its crystalline nature may have escaped
attention due to the limited means for microscopical
observations during the XIXth century where its granular
appearance without any obvious crystalline structure led
to the conclusion that it was amorphous, or, as stated by
Kohler [24], the samples were really just mixtures of
urate and uric acid.
2. Experimental
2.1. Origin of the sample
The calculus used for this study is from a 63 year old
man presenting recurrent stones for several years, often
expelled spontaneously. There were other calculi in the
kidneys and bladder. We received three calculi at the Tenon
Hospital, Paris; two were made of anhydrous uric acid.
Qualitative chemical analysis and IR spectra similarity led
to the conclusion that the third calculus could be an oxy-
purine potassium salt (no trace of Na, Mg or Ca). Given the
difference in composition, and probably of pH necessary for
their formation, it is likely that these calculi had different
anatomical origins, but we have no way of knowing more.
FTIR measurements are displayed in the supplementary
material. The presence of an amorphous component cannot
be excluded at this stage.
2.2. Synchrotron measurements
X-ray diffraction measurements were conducted on the
Cristal beamline of synchrotron SOLEIL (France). The X-ray
wavelength of 0.72442 Å selected using a double Si(111)
crystal monochromator was determined by recording a
diffraction pattern of a standard LaB6 powder (NIST SRM
660b). The sample, introduced in a glass capillary
(ø ¼ 0.7 mm), was mounted on a spinner rotating at 5 Hz toimprove particle orientation averaging. Data were collected
in Debye Scherrer mode using a 21 Si(111) crystals analyzer
[26].With this setup, threehighangular resolutiondiagrams
recorded in about two hourswere summed up since sample
degradation under the X-ray beamwas not signiﬁcant.
3. Structure determination and reﬁnement
Attempts of identiﬁcation by search-matching using the
Bruker EVA [27] software combined with the PDF database
[19] failed: no trace of the previously reported Ref. [18]
potassium urate (00-001-0302) was found in our sample.
Indexing of the synchrotron powder pattern of the potas-
sium quadriurate was realized by using the McMaille soft-
ware [28], leading to a primitive monoclinic cell. The
Figures of Merit (FoMs) were M20 ¼ 115.7 [29], F20 ¼ 518.2
(0.0012, 33) [30], andMcM20 ¼ 184.7 [31]. The space group
determinationwas unambiguously leading to P21/c. A quite
satisfactory Le Bail ﬁt [32] conﬁrmed the indexing and was
used to extract the intensities. Since the structure deter-
mination was undertaken without a detailed knowledge of
the chemical composition, several oxypurine molecules
were tested (uric acid, allantoin, hypoxanthine, and
xanthine) and various K: molecule ratios.
The cell volume suggested the possibility of two in-
dependent molecules. The structure solution was carried
out in direct space by using the ESPOIR software [33],
moving in the cell the molecules and the potassium
atoms by a Monte Carlo process. A clear best result was
obtained for two uric acid molecules and one potassium
atom in general positions. This implied that both inde-
pendent molecules had to be half-deprotonated, this
being realized through a disorder between two molecules
related by an inversion center, only one being deproto-
nated randomly. The IUPAC name is proposed to be po-
tassium 7,9-dihydro-3H-purine-2,6,8-trione 7,9-dihydro-
1H-purine-2,6,8(3H)-trione. The ﬁnal Rietveld [34] re-
ﬁnements were realized by using the FULLPROF software
[35]. All non-H atoms may be reﬁned freely, but this led
to highly distorted molecules so that 102 geometric re-
straints were applied on the uric acid and urate mole-
cules. These restraints were derived from the recent
accurate single crystal structure determination of
CaUr2$6H2O [16]. The two independent molecules in the
title compound were treated during the structure re-
ﬁnements as having both the C5H3.5N4O3 formula, one
hydrogen atom being half occupied. The half occupied H
atom sites are close to the inversion centers relating two
such molecules, only one having to be deprotonated
forming the urate anion and the other being a uric acid
molecule. Anisotropic line broadening was noticed and
treated by using the in-built FULLPROF spherical har-
monic options, concluding a negligible strain effect and
nanometer size of the platelet-like coherently diffracting
domains having the shortest mean size (290 Å) in the
direction of the a axis, 650 Å along b and 500 Å along c.
The Rietveld plot is shown in Fig. 1. The Rietveld reﬁne-
ment details are in Table 1, atom numbering in the two
independent uric acid molecules is shown in Fig. 2,
selected geometric parameters and the hydrogen bonds
are shown in Tables 2 and 3.
Fig. 1. Reﬁned synchrotron diffraction pattern for the potassium quadriurate. Red dots represent the observed data, the black line represents the calculated ones.
Bragg ticks are the peak positions and the blue curve shows the difference between the observed and calculated patterns.
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All the solid state calculations were performed using the
VASP code [36e38]. To optimize the structures, the hybrid
PBE0 functional [39] was used. Plane waves formed a basis
set and the calculations were performed using the
projector-augmented wave method [40,41] and atomic
pseudo-potentials [42]. The energy cutoff controlling theTable 1
Synchrotron XRD experimental parameters and Rietveld reﬁnement de-
tails of the potassium quadriurate.
Wavelength (Å) 0.72442
Synchrotron SOLEIL, France
Beamline CRISTAL
Monochromator Si(111)
Temperature (C) 23
Scan range (2q) 2e50
Step size (2q) 0.005
Chemical formula C10H7KN8O6
Chemical formula moiety K(C5H3N4O3)(C5H4N4O3)
Space group P21/c
Z 4
Cell parameters (Å, )
a 3.60504(9)
b 19.9293(7)
c 18.4841(6)
b 100.503(2)
Volume (Å3) 1305.75(7)
No. of contributing reﬂections 2176
No. of reﬁned parameters (total) 153
No. of atomic coordinates 99
No. of restraints 102
No. of isotropic thermal parameters 4
No. of background parameters 38
Proﬁle shape pseudo-Voigt
h 0.838(7)
U 0.72(3)
V 0.029(4)
W 0.00116(16)
Conventional Rietveld reliability factors (Rietveld, 1969)
RP (%) 9.46
RWP (%) 10.9
Rexp (%) 3.55
RB (%) 3.28
RF (%) 1.93accuracy of structure optimization calculations was in both
cases set to 700 eV and the Brillouin zones were sampled in
four k-points. The positions of all 128 atoms
(C40H28K4N32O24) in the computational P1 space group
description of the structure were fully relaxed while
keeping the lattice parameters of the respective cells ﬁxed
at the values obtained from diffraction data. Half occupied
hydrogen atoms used in Rietveld reﬁnement were replaced
by localized hydrogen atoms placed arbitrarily on respec-
tive N-atoms. Geometrical analysis of the optimized
structures done by means of the PLATON program [43]
showed that the originally proposed space group was cor-
rect. It has been previously proved that the DFT-optimized
structure provides intermolecular distances certainly more
accurate than those resulting from the Rietveld reﬁnement
which restrained the intramolecular interatomic distances
to a quasi-rigid model [see, e.g., 44,45]
5. Discussion
The organic moieties exhibit CeC, CeN and CeO bond
distances and angles obtained by minimization of the total
energy (Table 2), which match well those in uric acid ob-
tained from single crystal X-ray data [11]. Both molecules
are essentially planar with the maximum deviation from
the planes ﬁt to all non-hydrogen atoms of 0.05 Å and 0.1 Å,Fig. 2. Atom numbering in the two independent uric acid molecules, being
statistically half N3-deprotonated (or N13).
Table 2
Selected geometric parameters (Å, ) for the potassium quadriurate. The DFT-optimized values are in italics.
KeO3i 2.855 (6) 2.921 N7eC5 1.396 (8) 1.386
KeO3ii 2.828 (6) 2.876 N7eC8 1.354 (7) 1.357
KeO11iii 2.709 (5) 2.724 N9eC4 1.393 (8) 1.359
KeO1iv 2.817 (6) 2.701 N9eC8 1.391 (6) 1.392
KeO13iv 2.766 (6) 2.712 N11eC12 1.378 (5) 1.372
KeO1v 2.752 (6) 2.684 N11eC16 1.405 (7) 1.394
KeO13v 2.627 (6) 2.628 N13eC12 1.355 (4) 1.360
O1eC6 1.249 (5) 1.232 N13eC14 1.349 (7) 1.343
O2eC2 1.273 (6) 1.245 N17eC15 1.405 (8) 1.384
O3eC8 1.245 (7) 1.236 N17eC18 1.352 (5) 1.356
O11eC16 1.254 (6) 1.241 N19eC14 1.380 (4) 1.353
O12eC12 1.286 (6) 1.240 N19eC18 1.391 (9) 1.396
O13eC18 1.228 (6) 1.229 C4eC5 1.386 (5) 1.367
N1eC2 1.371 (5) 1.366 C5eC6 1.396 (9) 1.411
N1eC6 1.386 (7) 1.398 C14eC15 1.380 (7) 1.368
N3eC2 1.368 (8) 1.357 C15eC16 1.394 (4) 1.404
N3eC4 1.346 (5) 1.348
C2eN1eC6 127.5 (5) 127.61 N3eC4eN9 125.8 (4) 127.17
C2eN3eC4 113.9 (4) 118.87 N3eC4eC5 125.7 (4) 124.33
C5eN7eC8 108.5 (4) 109.23 N9eC4eC5 105.9 (4) 108.50
C4eN9eC8 109.3 (4) 108.58 N7eC5eC4 108.6 (5) 107.04
C12eN11eC16 126.5 (3) 127.12 N7eC5eC6 129.8 (4) 132.98
C12eN13eC14 114.4 (4) 119.01 C4eC5eC6 120.1 (4) 119.94
C15eN17eC18 108.2 (5) 109.43 O1eC6eN1 121.2 (6) 120.22
C14eN19eC18 108.9 (4) 108.41 O1eC6eC5 127.0 (4) 127.49
C6eN1eH1 114.9 (12) 115.00 N1eC6eC5 111.4 (3) 112.29
C2eN1eH1 117.0 (8) 117.00 O3eC8eN7 125.1 (4) 127.04
C4eN3eH3 121.6 (7) 122.00 O3eC8eN9 126.0 (5) 126.32
C2eN3eH3 115.2 (12) 119.00 N7eC8eN9 107.5 (5) 106.64
C5eN7eH7 124.0 (12) 128.00 O12eC12eN13 118.8 (4) 121.53
C8eN7eH7 125.3 (16) 123.00 N11eC12eN13 118.3 (3) 116.82
C8eN9eH9 125.5 (12) 128.00 O12eC12eN11 117.1 (3) 121.64
C4eN9eH9 122.8 (17) 124.00 N13eC14eN19 126.6 (5) 127.06
C12eN11eH11 116.9 (13) 116.00 N13eC14eC15 125.8 (3) 124.08
C16eN11eH11 112.7 (11) 116.00 N19eC14eC15 106.8 (5) 108.86
C14eN13eH13 119.1 (10) 118.00 N17eC15eC14 107.9 (3) 107.77
C12eN13eH13 116.8 (7) 122.00 N17eC15eC16 130.4 (6) 133.02
C15eN17eH17 123.9 (13) 127.00 C14eC15eC16 120.2 (5) 120.20
C18eN17eH17 127.7 (15) 123.00 O11eC16eC15 127.6 (5) 126.77
C14eN19eH19 125 (2) 125.00 N11eC16eC15 109.9 (5) 112.68
C18eN19eH19 126 (2) 127.00 O11eC16eN11 120.0 (4) 120.55
O2eC2eN1 119.5 (5) 121.5 5 O13eC18eN19 126.1 (4) 126.49
O2eC2eN3 120.9 (4) 121.53 N17eC18eN19 107.8 (4) 106.53
N1eC2eN3 118.6 (5) 116.91 O13eC18eN17 125.9 (7) 126.99
Symmetry codes: (i) x1, y, z1; (ii) x, y, z1; (iii) x, yþ1, zþ1; (iv) x, yþ3/2, z1/2; (v) xþ1, yþ3/2, z1/2.
Note: the use of 102 restraints divided the esd's by a factor two.
Table 3
Hydrogen geometry (Å,) for the potassium quadriurate. The DFT-
optimized values are in the second line (italics).
DeH/A DeH H/A D/A DeH/A
N1eH1/O11i 0.90 (2)
1.030
2.18 (4)
1.890
2.985 (8)
2.894
150 (5)
164.0
N3eH3/N3ii 0.893 (10)
1.100
1.626 (9)
1.610
2.500 (4)
2.708
165 (2)
179.0
N7eH7/O12iii 0.882 (19)
1.030
2.040 (17)
1.800
2.880 (5)
2.923
159 (2)
172.0
N9eH9/O2ii 0.804 (13)
1.030
2.187 (12)
2.020
2.890 (5)
2.992
146.3 (12)
157.0
N11eH11/O3iii 0.90 (2)
1.030
2.18 (2)
1.920
3.006 (5)
2.949
152 (2)
173.0
N13eH13/N13iii 0.900 (15)
1.100
1.893 (17)
1.550
2.517 (5)
2.645
124.7 (14)
174.0
N17eH17/O2iv 0.87 (4)
1.030
1.92 (4)
1.730
2.766 (8)
2.757
164 (3)
177.0
N19eH19/O12iii 0.80 (2)
1.030
2.15 (3)
1.880
2.908 (7)
2.888
160 (3)
164.0
Symmetry codes: (i)x1, yþ1/2,zþ3/2; (ii)x,yþ2, -zþ2; (iii)xþ1,
yþ1, zþ2; (iv) x1, y1/2, zþ3/2.
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a axis (Fig. 3) shows that every uric acid molecule is con-
nected to a urate anion through hydrogen bonds.
Potassium quadriurate is thus a co-crystal since it is
made of 1:1 M combination of uric acid and potassium
urate. Nevertheless, the uric acid molecule and the urate
anion are probably randomly distributed. This implies that
the centers of inversion are pseudo ones unless H3 and
H13 are placed exactly on them. Apart from the domi-
nating electrostatic cationeanion interactions, the pairs
uric acid-urate also form NeH…N and NeH…O hydrogen
bonds (Table 3). The N…N distances in these strong
hydrogen bonds obtained by solid state DFT structure
optimization compare 2.633(7) Å in 9-ethylguanine hem-
ihydrochloride [46], 2.692(4) Å in a supramolecular as-
sembly of phthalimide and 2-guanidinobenzimidazole
[47] or to 2.724(4) Å in D,L-histidyl-L, D-histidine penta-
hydrate [48]. When considering the large DeH…A angles,
the NeH…O bonds in the structure belong to stronger
Fig. 3. Projection along the short a axis of the potassium quadriurate structure showing the KO7 monocapped trigonal prisms and the pairs of urate and uric acid
molecules. ThehydrogenatomsH3andH13, close to inversion centers, are half occupied, then choosingonepositiondecides forwhichmolecule is deprotonatedornot.
D. Bazin et al. / C. R. Chimie 19 (2016) 1535e1541 1539hydrogen bonds. The D…A distances well-correspond to
the maximum on the histogram (2.892(3) Å) constructed
by using 1357 intermolecular NeH…O]C bonds [49]. The
oxygen atoms O2 and O12, which are not involved in the
potassium coordination sphere, are double acceptors of
hydrogen bonds (Fig. 4).
In the CaUr2$6H2O structure [16], only one of the two
urate molecules is directly coordinated to Ca2þ in a
bidentate fashion through N3 and O2, six water molecules
completing the CaO7N polyhedron. In the potassium
quadriurate the Kþ ion is seven-coordinated by oxygen
atoms from seven different molecules of either urate or uric
acid. Only two of the oxygen atoms of the uric acid mole-
cules and two of the urate anions (O1, O3 and O11, O13 with
KeO distances < 3 Å) are involved in the potassium coor-
dination forming KO7 monocapped trigonal prisms sharing
their triangular basis, building inﬁnite chains extending
along the short a axis. This kind of cell with a very short
parameter is characteristic of compounds with parallel
stacking of molecules. Interestingly, theoretical study of
interactions of urate with Kþ in vaccuo predicts a minimum
of energy when the cation interacts with oxygen and ni-
trogen of the six-membered ring [50]. In the structure of
the title compound both these atoms are involved in
hydrogen bonds and hence sterically blocked.
Analogous urate molecule stacking is known in sodium
urate monohydrate (short axis ¼ 3.567 (1) Å) with inﬁnitechains of NaO6 octahedra sharing edges along that short
axis [14]. Such a short axis is known too in the case of
ammonium urate (frequent in urolithiasis in Dalmatians)
for which a monoclinic cell with b ¼ 3.528(1) Å was pro-
posed [51] as well as a triclinic one with a¼ 3.650(3) Å [15]
from powder data indexing. Such a close stacking (3.664(1)
Å) of molecules is also the case for purine [52]. Anyway, the
sodium urate crystallizes in needles elongated along this
short axis, contrarily to the quadriurate of potassium for
which this direction is apparently the most difﬁcult for
crystal growth (platelets).
6. Conclusion
To our knowledge, this is the ﬁrst observation of such a
combination by hydrogen bonding of one uric acid mole-
cule with one N3-deprotonated molecule. We have to
recognize the strong expertize of the XIXth century scien-
tists who proposed the quadriurate's existence well before
any X-ray crystallography possibility of characterization. Sir
William Roberts in 1892 [23] asked “what is the chemical
nature of this substance, what are its physiological analogies
and pathological relations? What is the constitution of this
substance? Is it merely a mechanical mixture of biurate with
varying quantities of free uric acid or a new and third order of
uric acid salts, differing essentially from the two regular or-
ders previously recognized?” In spite of Kohler [24] declaring
Fig. 4. Hydrogen bonds are shown by dashed lines, symmetry codes are deﬁned in Table 3. Note that H3 and H13 atoms attached to N3/N13 are shown in both
possible positions. (In the color version nitrogen atoms are in blue, oxygen in red and carbon in gray).
D. Bazin et al. / C. R. Chimie 19 (2016) 1535e15411540that no such body as quadriurate exists, we have answered
here to the ﬁrst part of the question and established the
reality of the potassium quadriurate as belonging to a third
order of uric acid salts, thanks to powder diffraction mod-
ern methodologies allowing crystal structure determina-
tion. The possible existence of sodium or ammonium
quadriurates is now questioned but highly probable (their
mixture with potassium quadriurate being the main con-
stituent of bird and snake excretions). Finally, the naming is
confusing since the still crystallographically uncharac-
terized KC5H3N4O3 is generally called potassium urate, then
the title compound would logically be a biurate in the
modern nomenclature, not a quadriurate. Concerning
physiological implications, the current views about the
excretion of uric acid, which is very poorly soluble, are that
the urates, which are more soluble, pass into the excretory
tubules and that the urine is later acidiﬁed. The quadriurate
of potassium, highly soluble in urines, provides a solution
for the elimination of uric acid which would crystallize only
after the potassium quadriurate degradation into potas-
sium urate and uric acid in water. An explanation for the
efﬁciency of potassium citrate on urolithiasis may come
from the way a urate anion can link by three hydrogen
bonds to a uric acid molecule and form a new bigger anion
compensated by only one Kþ cation (or Naþ, NH4þ, etc).
This fact may well lead to the formulation of a new hy-
pothesis about urate transport, a subject having attracted
considerable interest in the past 150 years [53].Acknowledgments
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